Good brain penetration. Maybe useful for stopping vertical transmission. No data on lymph or brain penetration, but the manufacturer claims it gets in the brain. Strong in combo. This was down from 70 per cent of participants at six months.
Current data is unclear.
Small studies, but one triple combo study showed that at 10 months, HIV remained below detection. Compared to other antivirals, the effect is small. Another study in combo with AZT fared only slightly better. An average increase of a little over 100 T-cells noted in one study. This increase remained throughout study.